Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1,850 | 1 | 65.8% |
| Food and Beverage | $962.39 | 34 | 34.2% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otonomy, Inc. | $1,850 | 1 | $0 (2017) |
| Intersect ENT, Inc. | $272.61 | 6 | $0 (2020) |
| Medtronic, Inc. | $146.23 | 2 | $0 (2024) |
| OptiNose US, Inc. | $131.17 | 7 | $0 (2020) |
| ARBOR PHARMACEUTICALS, INC. | $51.49 | 3 | $0 (2018) |
| Hikma Pharmaceuticals USA | $50.50 | 1 | $0 (2024) |
| Aerin Medical Inc. | $48.28 | 1 | $0 (2020) |
| Acclarent, Inc | $42.29 | 2 | $0 (2021) |
| GENZYME CORPORATION | $27.98 | 1 | $0 (2023) |
| Inspire Medical Systems, Inc. | $23.04 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $223.00 | 4 | Medtronic, Inc. ($126.84) |
| 2023 | $47.37 | 2 | GENZYME CORPORATION ($27.98) |
| 2021 | $24.89 | 1 | Acclarent, Inc ($24.89) |
| 2020 | $117.93 | 5 | Aerin Medical Inc. ($48.28) |
| 2019 | $327.53 | 10 | Intersect ENT, Inc. ($190.73) |
| 2018 | $159.15 | 8 | ARBOR PHARMACEUTICALS, INC. ($51.49) |
| 2017 | $1,913 | 5 | Otonomy, Inc. ($1,850) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Medtronic, Inc. | NOVAPAK (Device) | Food and Beverage | In-kind items and services | $126.84 | General |
| Category: Dressing, stents and packing | ||||||
| 09/03/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: IMMUNOLOGY | ||||||
| 05/20/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $50.50 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 03/26/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: NEUROLOGY | ||||||
| 08/16/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: Immunology | ||||||
| 06/15/2023 | Medtronic, Inc. | Sinuva (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/22/2021 | Acclarent, Inc | ACCLARENT Balloon Inflation Device (Device) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Rhinology Laryngology | ||||||
| 11/03/2020 | Aerin Medical Inc. | VivAer (Device), RhinAer | Food and Beverage | In-kind items and services | $48.28 | General |
| Category: Ear, Nose & Throat | ||||||
| 07/29/2020 | Intersect ENT, Inc. | SINUVA (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 02/18/2020 | Intersect ENT, Inc. | SINUVA (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 02/12/2020 | Stryker Corporation | ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $21.45 | General |
| Category: ENTELLUS | ||||||
| 01/21/2020 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/19/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/23/2019 | Intersect ENT, Inc. | PROPEL (Device) | Food and Beverage | In-kind items and services | $93.79 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/27/2019 | Intersect ENT, Inc. | PROPEL (Device) | Food and Beverage | In-kind items and services | $33.34 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/07/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/06/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 05/30/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/30/2019 | Intersect ENT, Inc. | PROPEL (Device) | Food and Beverage | In-kind items and services | $63.60 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/18/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 03/20/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 02/19/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/17/2018 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Pediatrics/Neonatology | ||||||
| 10/11/2018 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Pediatrics/Neonatology | ||||||
| 09/25/2018 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Pediatrics/Neonatology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PHASE 3 STUDY OF OTO-201 IN ACUTE OTITIS EXTERNA | Otonomy, Inc. | $1,850 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,429 | 1,738 | $550,220 | $154,053 |
| 2022 | 11 | 1,244 | 1,567 | $516,139 | $138,755 |
| 2021 | 10 | 1,058 | 1,411 | $384,024 | $116,637 |
| 2020 | 10 | 1,052 | 1,365 | $312,828 | $102,763 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 234 | 317 | $242,822 | $48,699 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 227 | 288 | $64,800 | $31,306 | 48.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 297 | 297 | $59,400 | $27,552 | 46.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 219 | 258 | $55,994 | $19,358 | 34.6% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 76 | 103 | $29,870 | $11,080 | 37.1% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 237 | 309 | $81,389 | $10,218 | 12.6% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2023 | 112 | 115 | $12,535 | $4,952 | 39.5% |
| 95992 | Repositioning exercises of head for treatment of dizziness, each day | Office | 2023 | 14 | 14 | $1,190 | $528.22 | 44.4% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 13 | 37 | $2,220 | $360.74 | 16.2% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 210 | 319 | $244,354 | $51,694 | 21.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 237 | 315 | $68,355 | $23,073 | 33.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 240 | 240 | $48,000 | $20,767 | 43.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 147 | 183 | $41,175 | $19,318 | 46.9% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 221 | 285 | $74,896 | $9,442 | 12.6% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 58 | 75 | $21,750 | $8,585 | 39.5% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2022 | 84 | 86 | $9,374 | $3,321 | 35.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,960 | $1,491 | 37.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $1,430 | $403.39 | 28.2% |
| 95992 | Repositioning exercises of head for treatment of dizziness, each day | Office | 2022 | 11 | 13 | $1,105 | $384.21 | 34.8% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 14 | 29 | $1,740 | $274.99 | 15.8% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2021 | 160 | 253 | $156,259 | $43,984 | 28.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 221 | 315 | $58,641 | $23,564 | 40.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 205 | 205 | $41,000 | $17,524 | 42.7% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 223 | 288 | $73,221 | $10,066 | 13.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 92 | $20,700 | $9,588 | 46.3% |
About Dr. Eric Munzer, D.O
Dr. Eric Munzer, D.O is a Otolaryngology healthcare provider based in New Windsor, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1063533404.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Munzer, D.O has received a total of $2,812 in payments from pharmaceutical and medical device companies, with $223.00 received in 2024. These payments were reported across 35 transactions from 20 companies. The most common payment nature is "" ($1,850).
As a Medicare-enrolled provider, Munzer has provided services to 4,783 Medicare beneficiaries, totaling 6,081 services with total Medicare billing of $512,208. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Otolaryngology
- Other Specialties Otolaryngology/Facial Plastic Surgery, Otolaryngology
- Location New Windsor, NY
- Active Since 04/03/2007
- Last Updated 10/12/2023
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1063533404
Products in Payments
- PROPEL (Device) $238.66
- Xhance (Drug) $131.17
- NOVAPAK (Device) $126.84
- Otovel (Drug) $51.49
- Ryaltris (Drug) $50.50
- VivAer (Device) $48.28
- DUPIXENT (Biological) $47.86
- SINUVA (Drug) $33.95
- ACCLARENT Balloon Inflation Device (Device) $24.89
- INSPIRE (Device) $23.04
- NUCALA (Biological) $22.62
- ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $21.45
- Sinuva (Drug) $19.39
- NUVENT (Device) $18.36
- ACCLARENT AERA Eustachian Tube Balloon Dilation System (Device) $17.40
- CIPRODEX (Drug) $17.22
- ThunderBeat (Device) $16.70
- XprESS Multi-Sinus Dilation System (Device) $14.33
- Dymista (Drug) $13.57
- OFIRMEV (Drug) $12.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.